312 related articles for article (PubMed ID: 30954537)
1. An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62.
Foster A; Scott D; Layfield R; Rea SL
Mol Cell Neurosci; 2019 Jul; 98():32-45. PubMed ID: 30954537
[TBL] [Abstract][Full Text] [Related]
2. ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling.
Goode A; Rea S; Sultana M; Shaw B; Searle MS; Layfield R
Mol Cell Neurosci; 2016 Oct; 76():52-58. PubMed ID: 27554286
[TBL] [Abstract][Full Text] [Related]
3. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway.
Deng Z; Lim J; Wang Q; Purtell K; Wu S; Palomo GM; Tan H; Manfredi G; Zhao Y; Peng J; Hu B; Chen S; Yue Z
Autophagy; 2020 May; 16(5):917-931. PubMed ID: 31362587
[TBL] [Abstract][Full Text] [Related]
4. ALS-associated TBK1 variant p.G175S is defective in phosphorylation of p62 and impacts TBK1-mediated signalling and TDP-43 autophagic degradation.
Foster AD; Downing P; Figredo E; Polain N; Stott A; Layfield R; Rea SL
Mol Cell Neurosci; 2020 Oct; 108():103539. PubMed ID: 32835772
[TBL] [Abstract][Full Text] [Related]
5. Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant.
Kageyama S; Saito T; Obata M; Koide RH; Ichimura Y; Komatsu M
Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29339380
[TBL] [Abstract][Full Text] [Related]
6. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
[TBL] [Abstract][Full Text] [Related]
7. TAK1 Regulates the Nrf2 Antioxidant System Through Modulating p62/SQSTM1.
Hashimoto K; Simmons AN; Kajino-Sakamoto R; Tsuji Y; Ninomiya-Tsuji J
Antioxid Redox Signal; 2016 Dec; 25(17):953-964. PubMed ID: 27245349
[TBL] [Abstract][Full Text] [Related]
8. Phase-separated protein droplets of amyotrophic lateral sclerosis-associated p62/SQSTM1 mutants show reduced inner fluidity.
Faruk MO; Ichimura Y; Kageyama S; Komatsu-Hirota S; El-Gowily AH; Sou YS; Koike M; Noda NN; Komatsu M
J Biol Chem; 2021 Dec; 297(6):101405. PubMed ID: 34774801
[TBL] [Abstract][Full Text] [Related]
9. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription.
Jain A; Lamark T; Sjøttem E; Larsen KB; Awuh JA; Øvervatn A; McMahon M; Hayes JD; Johansen T
J Biol Chem; 2010 Jul; 285(29):22576-91. PubMed ID: 20452972
[TBL] [Abstract][Full Text] [Related]
10. P62/SQSTM1 upregulates NQO1 transcription via Nrf2/Keap1a signaling pathway to resist microcystins-induced oxidative stress in freshwater mussel Cristaria plicata.
Wu J; Hou S; Yang L; Wang Y; Wen C; Guo Y; Luo S; Fang H; Jiao H; Xu H; Zhang S
Aquat Toxicol; 2023 Feb; 255():106398. PubMed ID: 36669434
[TBL] [Abstract][Full Text] [Related]
11. NBR1-mediated p62-liquid droplets enhance the Keap1-Nrf2 system.
Sánchez-Martín P; Sou YS; Kageyama S; Koike M; Waguri S; Komatsu M
EMBO Rep; 2020 Mar; 21(3):e48902. PubMed ID: 31916398
[TBL] [Abstract][Full Text] [Related]
12. The S349T mutation of SQSTM1 links Keap1/Nrf2 signalling to Paget's disease of bone.
Wright T; Rea SL; Goode A; Bennett AJ; Ratajczak T; Long JE; Searle MS; Goldring CE; Park BK; Copple IM; Layfield R
Bone; 2013 Feb; 52(2):699-706. PubMed ID: 23117207
[TBL] [Abstract][Full Text] [Related]
13. SQSTM1 mutations--bridging Paget disease of bone and ALS/FTLD.
Rea SL; Majcher V; Searle MS; Layfield R
Exp Cell Res; 2014 Jul; 325(1):27-37. PubMed ID: 24486447
[TBL] [Abstract][Full Text] [Related]
14. Severe Fever with Thrombocytopenia Syndrome Virus NSs Interacts with TRIM21 To Activate the p62-Keap1-Nrf2 Pathway.
Choi Y; Jiang Z; Shin WJ; Jung JU
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852783
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.
Gjyshi O; Flaherty S; Veettil MV; Johnson KE; Chandran B; Bottero V
J Virol; 2015 Feb; 89(4):2268-86. PubMed ID: 25505069
[TBL] [Abstract][Full Text] [Related]
16. MOAP-1-mediated dissociation of p62/SQSTM1 bodies releases Keap1 and suppresses Nrf2 signaling.
Tan CT; Chang HC; Zhou Q; Yu C; Fu NY; Sabapathy K; Yu VC
EMBO Rep; 2021 Jan; 22(1):e50854. PubMed ID: 33393215
[TBL] [Abstract][Full Text] [Related]
17. Activation of p62-keap1-Nrf2 antioxidant pathway in the early stage of acetaminophen-induced acute liver injury in mice.
Shen Z; Wang Y; Su Z; Kou R; Xie K; Song F
Chem Biol Interact; 2018 Feb; 282():22-28. PubMed ID: 29331651
[TBL] [Abstract][Full Text] [Related]
18. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Rubino E; Rainero I; Chiò A; Rogaeva E; Galimberti D; Fenoglio P; Grinberg Y; Isaia G; Calvo A; Gentile S; Bruni AC; St George-Hyslop PH; Scarpini E; Gallone S; Pinessi L;
Neurology; 2012 Oct; 79(15):1556-62. PubMed ID: 22972638
[TBL] [Abstract][Full Text] [Related]
19. Effect of p62/SQSTM1 polyubiquitination on its autophagic adaptor function and cellular survival under oxidative stress induced by arsenite.
Lee H; Kim MN; Ryu KY
Biochem Biophys Res Commun; 2017 May; 486(3):839-844. PubMed ID: 28359760
[TBL] [Abstract][Full Text] [Related]
20. New Target of Oxidative Stress Regulation in Cochleae: Alternative Splicing of the p62/Sqstm1 Gene.
Li P; Bing D; Wang X; Chen J; Du Z; Sun Y; Qi F; Chu H
J Mol Neurosci; 2022 Apr; 72(4):830-840. PubMed ID: 35048235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
